Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis
- PMID: 16879890
- DOI: 10.1016/j.jhep.2006.05.010
Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis
Abstract
Background/aims: Primary sclerosing cholangitis (PSC) is associated with a high risk of cholangiocarcinoma development. Efforts should be made to detect early neoplastic changes that can be radically treated by liver transplantation.
Methods: In this prospective case series we obtained brush cytology specimens from bile duct strictures in 61 consecutive PSC patients. The cytological classifications were compared with histopathological findings in bile ducts from explanted livers or clinical outcome.
Results: Among patients with cytological low-grade (n=9; 15%) or high-grade dysplasia/adenocarcinoma (n=13; 21%), 8 (36%) proved to have cholangiocarcinoma and 7 (32%) to have high-grade dysplasia (i.e. cholangiocarcinoma in situ) in bile ducts from explanted livers. The sensitivity, specificity, positive- and negative predictive values, and accuracy of brush cytology in diagnosis of biliary malignancy were 100%, 84%, 68%, 100%, and 88% for the combination of low-grade and high-grade dysplasia/adenocarcinoma and 73%, 95%, 85%, 91%, and 90% for high-grade dysplasia/adenocarcinoma only. All patients with high-grade biliary epithelial dysplasia in explanted bile ducts were tumour free at follow-up.
Conclusions: Brush cytology from bile duct strictures in PSC patients can detect cholangiocarcinoma in situ. Patients with cytological low-grade and high-grade dysplasia/adenocarcinoma are currently referred for liver transplantation in our hospital.
Comment in
-
Diagnosis of cholangiocarcinoma in patients with PSC: a sight on cytology.J Hepatol. 2006 Oct;45(4):476-9. doi: 10.1016/j.jhep.2006.07.006. Epub 2006 Jul 25. J Hepatol. 2006. PMID: 16901574 Review. No abstract available.
Similar articles
-
Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.Am J Surg Pathol. 2010 Jan;34(1):27-34. doi: 10.1097/PAS.0b013e3181bc96f9. Am J Surg Pathol. 2010. PMID: 19898228
-
Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.Am J Surg Pathol. 2007 Jun;31(6):907-13. doi: 10.1097/01.pas.0000213435.99492.8a. Am J Surg Pathol. 2007. PMID: 17527079
-
Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis.Endoscopy. 2006 Jul;38(7):665-9. doi: 10.1055/s-2006-925257. Epub 2006 Apr 27. Endoscopy. 2006. PMID: 16673310
-
Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.Rev Gastroenterol Disord. 2009 Spring;9(2):E41-7. Rev Gastroenterol Disord. 2009. PMID: 19668124 Review.
-
Diagnosis of cholangiocarcinoma in patients with PSC: a sight on cytology.J Hepatol. 2006 Oct;45(4):476-9. doi: 10.1016/j.jhep.2006.07.006. Epub 2006 Jul 25. J Hepatol. 2006. PMID: 16901574 Review. No abstract available.
Cited by
-
Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management.Clin Gastroenterol Hepatol. 2015 Nov;13(12):2152-65. doi: 10.1016/j.cgh.2015.05.035. Epub 2015 Jun 5. Clin Gastroenterol Hepatol. 2015. PMID: 26051390 Free PMC article. Review.
-
Still elusive: Developments in the accurate diagnosis of indeterminate biliary strictures.World J Gastrointest Endosc. 2024 Jun 16;16(6):297-304. doi: 10.4253/wjge.v16.i6.297. World J Gastrointest Endosc. 2024. PMID: 38946851 Free PMC article. Review.
-
Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis - The promise of DNA methylation and molecular biomarkers.JHEP Rep. 2020 Jul 11;2(5):100143. doi: 10.1016/j.jhepr.2020.100143. eCollection 2020 Oct. JHEP Rep. 2020. PMID: 32939446 Free PMC article. Review.
-
Analytical review of diagnosis and treatment strategies for dominant bile duct strictures in patients with primary sclerosing cholangitis.HPB (Oxford). 2011 Feb;13(2):79-90. doi: 10.1111/j.1477-2574.2010.00268.x. HPB (Oxford). 2011. PMID: 21241424 Free PMC article. Review.
-
Hepatobiliary manifestations of ulcerative colitis: an example of gut-liver crosstalk.Gastroenterol Rep (Oxf). 2014 Aug;2(3):193-200. doi: 10.1093/gastro/gou036. Epub 2014 Jun 20. Gastroenterol Rep (Oxf). 2014. PMID: 24951514 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical